OpenEvidence Founder on Medical AI: Investment Paying Dividends

OpenEvidence: AI Co-Pilot for Physicians

• 💡 OpenEvidence offers an AI co-pilot for doctors designed to increase accuracy in patient care.
• 🎯 The product functions like a ChatGPT for doctors, providing assistance with high-stakes clinical decisions at the point of care.
• 🚀 Over 100 million Americans are expected to be treated by doctors using OpenEvidence this year.

Medical AI's Current Impact

• ⚡ In October alone, there were 17 million AI clinical consultations from verified US healthcare professionals.
• 📈 This demonstrates that medical AI is here and now, proving the nation's investment in AI infrastructure is already yielding significant returns.

Physician as the Last Mile

• 🧠 OpenEvidence's philosophy emphasizes that the doctor is always the last mile, never making medical recommendations directly.
• 🛠️ Similar to financial software where traders remain in control, AI in medicine acts as a force multiplier and brain extender for physicians.
• ⚠️ The projected shortage of 100,000 doctors by the end of the decade underscores the need for such tools to combat burnout and information overload.

Competitive Advantage and Training Data

• 🤝 OpenEvidence's largest investor is Google, indicating strong backing and strategic alignment.
• 🎯 The company's competitive advantage lies in its focused approach on building specialized tools for physicians, unlike broader horizontal AI applications.
• 📚 A key differentiator is training on data from strategic partnerships with leading medical sources like the New England Journal of Medicine and the American Medical Association, ensuring accuracy from gold-standard knowledge.
• 🌐 This contrasts with horizontal AI applications often trained on the broader, less curated open internet.